2,3-二氢喹唑啉-4(1H)-酮类化合物的合成研究进展

doi:10.6023/cjoc201903025

有机化学 ›› 2019, Vol. 39 ›› Issue (9): 2392-2402.DOI: 10.6023/cjoc201903025 上一篇下一篇

综述与进展

2,3-二氢喹唑啉-4(1H)-酮类化合物的合成研究进展

张晓鹏, 朱妍洁, 朱奕崧, 李政伟, 张贵生

河南师范大学化学化工学院绿色化学介质与反应教育部重点实验室河南省有机功能分子与药物创新重点实验室精细化学品绿色制造河南省协同创新中心新乡 453007

收稿日期:2019-03-14 修回日期:2019-04-11 发布日期:2019-04-26
通讯作者: 张晓鹏 E-mail:zhangxiaopengv@sina.com
基金资助:
国家自然科学基金（Nos.21772033，U1604285）、高等学校学科创新引智计划（111计划，No.D17007）资助项目.

Advances in Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones

Zhang Xiaopeng, Zhu Yanjie, Zhu Yisong, Li Zhengwei, Zhang Guisheng

Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang 453007

Received:2019-03-14 Revised:2019-04-11 Published:2019-04-26
Contact: 10.6023/cjoc201903025 E-mail:zhangxiaopengv@sina.com
Supported by:
Project supported by the National Natural Science Foundation of China (Nos. 21772033, U1604285) and the Program of Introducing Talents of Discipline to Universities (111 Project, No. D17007).

文章分享

摘要/Abstract

2，3-二氢喹唑啉-4（1H）-酮是一类重要的含氮稠杂环化合物，具有广泛的药理及生物活性，在药物合成与研发领域有着重要应用价值，因而其合成方法也倍受人们关注.归纳总结了2，3-二氢喹唑啉-4（1H）-酮类化合物的合成研究进展，主要介绍了以邻氨基苯甲酰胺、靛红酸酐、邻硝基苯甲酰胺、邻叠氮基苯甲酰胺、邻溴苯甲酰胺、邻溴苯甲腈、邻氨基苯甲酸、邻氨基苯甲腈、邻氨基N-甲基-N-丙二烯基苯甲酰胺、N-烷基苯胺等为起始原料的2，3-二氢喹唑啉-4（1H）-酮类化合物的合成研究进展概况及其反应机理.最后对该类化合物的合成研究进展进行了总结，并对其发展前景进行了展望.

关键词: 2,3-二氢喹唑啉-4(1H)-酮, 邻氨基苯甲酰胺, 靛红酸酐, N-烷基苯胺, C-H活化功能化, 钯催化

2,3-Dihydroquinazolin-4(1H)-one compounds are an important class of nitrogen-containing fused heterocycles, which possess a wide range of pharmacological and biological activities and have important applications in the fields of synthesis and research & development of drugs. Therefore, its synthetic methods have also attracted considerable attention. In this paper, the main advances in the synthesis of 2,3-dihydroquinazolin-4(1H)-ones and their proposed reaction mechanisms from the raw materials such as o-aminobenzamides, isatoic anhydrides, o-nitrobenzamides, o-azidobenzamide, o-bromo-benzamide, o-bromobenzonitrile, o-aminobenzoic acids, o-aminobenzonitrile, o-amino-N-(propa-1,2-dienyl)benzamides, and N-alkyl anilines were introduced and reviewed, respectively. Finally, the synthesis of these compounds was summarized and the prospect of their development was prospected.

Key words: 2,3-dihydroquinazolin-4(1H)-one, o-aminobenzamides, isatoic anhydrides, N-alkyl anilines, C-H activation &, functionalization, palladium catalysis

引用此文

张晓鹏, 朱妍洁, 朱奕崧, 李政伟, 张贵生. 2,3-二氢喹唑啉-4(1H)-酮类化合物的合成研究进展[J]. 有机化学, 2019, 39(9): 2392-2402.

Zhang Xiaopeng, Zhu Yanjie, Zhu Yisong, Li Zhengwei, Zhang Guisheng. Advances in Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones[J]. Chin. J. Org. Chem., 2019, 39(9): 2392-2402.

导出引用 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

分享此文

参考文献

[1] Kamble, A. A.; Kamble, R. R.; Chougala, L. S.; Kadadevarmath, J. S.; Maidur, S. R.; Patil, P. S.; Kumbar, M. N.; Marganakop, S. B. ChemistrySelect 2017, 2, 6882.
[2] Kamal, A.; Bharathi, E. V.; Reddy, J. S.; Ramaiah, M. J.; Dastagiri, D.; Reddy, M. K.; Viswanath, A.; Reddy, T. L.; Shaik, T. B.; Pushpavalli, S. N. C. V. L.; Bhadra, M. P. Eur. J. Med. Chem. 2011, 46, 691.
[3] Chinigo, G. M.; Paige, M.; Grindrod, S.; Hamel, E.; Dakshana-murthy, S.; Chruszcz, M.; Minor, W.; Brown, M. L. J. Med. Chem. 2008, 51, 4620.
[4] Roopan, S. M.; Khan, F. N.; Jin, J. S.; Kumar, R. S. Res. Chem. Intermed. 2011, 37, 919.
[5] Liao, C. H.; Pan, S. L.; Guh, J. H.; Chang, Y. L.; Pai, H. C.; Lin, C. H.; Teng, C. M. Carcinogenesis 2005, 26, 968.
[6] Hour, M. J.; Huang, L. J.; Kuo, S. C.; Xia, Y.; Bastow, K.; Nakanishi, Y.; Hamel, E.; Lee, K. H. J. Med. Chem. 2000, 43, 4479.
[7] Li, X. Q.; Wang, R. T.; Liu, Y.; Liu, Y.; Zheng, H.; Feng, Y. B.; Zhao, N.; Geng, H. B.; Zhang, W. Z.; Wen, A. D. BMC Pharmacol. Toxicol. 2017, 18, 73.
[8] Ibrahim, S. M.; Abo-Kul, M.; Soltan, M. K.; Barakat, W.; Helal, A. S. Med. Chem. 2014, 4, 351.
[9] Cheng, X.; Vellalath, S.; Goddard, R.; List, B. J. Am. Chem. Soc. 2008, 130, 15786.
[10] Hemalatha, K.; Madhumitha, G.; Vasavi, C. S.; Munusami, P. J. Photochem. Photobiol. B 2015, 143, 139.
[11] Yu, H.; Jin, H. W.; Gong, W. Z.; Wang, Z. L.; Liang, H. P. Molecules 2013, 18, 1826.
[12] El-Sabbagh, O. I.; Ibrahim, S. M.; Baraka, M. M.; Kothayer, H. Arch. Pharm. Chem. Life Sci. 2010, 343, 274.
[13] Zhang, J.; Cheng, P.; Ma, Y. M.; Liu, J.; Miao, Z.; Ren, D. C.; Fan, C.; Liang, M.; Liu, L. Tetrahedron Lett. 2016, 57, 5271.
[14] Mohammadi, A. A.; Rohi, H.; Soorkic, A. A. J. Heterocycl. Chem. 2013, 50, 1129.
[15] Xu, Z. H.; Zhang, Y. P.; Fu, H. C.; Zhong, H. M.; Hong, K.; Zhu, W. M. Bioorg. Med. Chem. Lett. 2011, 21, 4005.
[16] Ferrando, C.; Foy, J. M.; Pratt, C. N. F. W.; Purvis, J. R. J. Pharm. Pharmacol. 1981, 33, 219.
[17] Steinmuller, S. R.; Puschett, J. B. Kidney Int. 1972, 1, 169.
[18] Wang, Z. W.; Wang, M. X.; Yao, X.; Li, Y.; Tan, J.; Wang, L. Z.; Qiao, W. T.; Geng, Y. Q.;, Liu, Y. X.; Wang, Q. M. Eur. J. Med. Chem. 2012, 53, 275.
[19] Kothayer, H.; Ibrahim, S. M.; Soltan, M. K.; Rezq, S.; Mahmoud, S. S. Drug Dev. Res. 2019, 80, 343..
[20] Derbyshire, E. R.; Min, J.; Guiguemde, W. A.; Clark, J. A.; Connelly, M. C.; Magalhães, A. D.; Guy, R. K.; Clardy, J. Antimicrob. Agents Ch. 2014, 58, 1516.
[21] Hemalatha, K.; Madhumitha, G. J. Lumin. 2016, 178, 163.
[22] Singh, M.; Raghav, N. Bioorg. Chem. 2015, 59, 12.
[23] Sultana, N.; Sarfraz, M.; Tanoli, S. T.; Akram, M. S.; Sadiq, A.; Rashid, U.; Tariq, M. I. Bioorg. Chem. 2017, 72, 256.
[24] Sarfraz, M.; Sultana, N.; Rashid, U.; Akram, M. S.; Sadiq, A.; Tariq, M. I. Bioorg. Chem. 2017, 70, 237.
[25] Xing, J. H.; Yang, L. Y.; Yang, Y. F.; Zhao, L. L.; Wei, Q. Q.; Zhang, J.; Zhou, J. P.; Zhang, H. B. Eur. J. Med. Chem. 2017, 125, 411.
[26] Birch, H. L.; Buckley, G. M.; Davies, N.; Dyke, H. J.; Frost, E. J.; Gilbert, P. J.; Hannah, D. R.; Haughan, A. F.; Madigan, M. J.; Morgan, T.; Pitt, W. R.; Ratcliffe, A. J.; Ray, N. C.; Richard, M. D.; Sharpe, A.; Taylor, A. J.; Whitworth, J. M.; Williams, S. C. Bioorg. Med. Chem. Lett. 2005, 15, 5335.
[27] Katoh, T.; Takai, T.; Yukawa, T.; Tsukamoto, T.; Watanabe, E.; Mototani, H.; Arita, T.; Hayashi, H.; Nakagawa, H.; Klein, M. G.; Zou, H.; Sang, B. C.; Snell, G.; Nakada, Y. Bioorg. Med. Chem. 2016, 24, 2466.
[28] Zhang, H.; Liu, H.; Luo, X.; Wang, Y. X.; Liu, Y.; Jin, H. W.; Liu, Z. M.; Yang, W.; Yu, P. L.; Zhang, L. R.; Zhang, L. H. Eur. J. Med. Chem. 2018, 152, 235.
[29] Meinwald, Y. C.; Meinwald, J.; Eisner, T. Science 1966, 154, 390.
[30] Wang, X.; Yin, J.; Shi, L.; Zhang, G. P.; Song, B. A. Eur. J. Med. Chem. 2014, 77, 65.
[31] Giri, R.; Lam, J. K.; Yu, J. Q. J. Am. Chem. Soc. 2010, 132, 686.
[32] Diener, M. E.; Metrano, A. J.; Kusano, S.; Miller, S. J. J. Am. Chem. Soc. 2015, 137, 12369.
[33] Akyüz, G.; Mente?e, E.; Emirik, M.; Balta?, N. Bioorg. Chem. 2018, 80, 121.
[34] Perreault, S.; Chandrasekhar, J.; Cui, Z. H.; Evarts, J.; Hao, J.; Kaplan, J. A.; Kashishian, A.; Keegan, K. S.; Kenney, T.; Koditek, D.; Lad, L.; Lepist, E. I.; McGrath, M. E.; Patel, L.; Phillips, B.; Therrien, J.; Treiberg, J.; Yahiaoui, A.; Phillips, G. J. Med. Chem. 2017, 60, 1555.
[35] Badolato, M.; Aiello, F.; Neamati, N. RSC Adv. 2018, 8, 20894.
[36] Cheng, X.; Vellalath, S.; Goddard, R.; List, Benjamin. J. Am. Chem. Soc. 2008, 130, 15786.
[37] Deng, T.; Wang, H. J.; Cai, C. J. Fluorine Chem. 2015, 169, 72.
[38] Tran, P. H.; Bui, T. P. T.; Lam, X. Q. B.; Nguyen, X. T. T. RSC Adv. 2018, 8, 36392.
[39] Sharma, M.; Pandey, S.; Chauhan, K.; Sharma, D.; Kumar, B.; Chauhan, P. M. S. J. Org. Chem. 2012, 77, 929.
[40] Sriramoju, V.; Kurva, S.; Chong, Y.; Madabhushi, S. New J. Chem. 2018, 42, 3188.
[41] Yamaguchi, K.; Kawaguchi, S.; Sonoda, M.; Tanimori, S.; Ogawa, A. Tetrahedron Lett. 2017, 58, 4043.
[42] Patil, N. T.; Lakshmi, P. G. V. V.; Singh, V. Eur. J. Org. Chem. 2010, 4719.
[43] Patil, N. T.; Kavthe, R. D.; Raut, V. S.; Shinde, V. S.; Sridhar, B. J. Org. Chem. 2010, 75, 1277.
[44] Sawatzky, E.; Wehle, S.; Kling, B.; Wendrich, J.; Bringmann, G.; Sotriffer, C. A.; Heilmann, J.; Decker, M. J. Med. Chem. 2016, 59, 2067.
[45] Noel, R.; Gupta, N.; Pons, V.; Goudet, A.; Garcia-Castillo, M. D.; Michau, A.; Martinez, J.; Buisson, D. A.; Johannes, L.; Gillet, D.; Barbier, J.; Cintrat, J. C. J. Med. Chem. 2013, 56, 3404.
[46] Razavi, N.; Akhlaghinia, B. New J. Chem. 2016, 40, 447.
[47] Zhang, J.; Ren, D. C.; Ma, Y. M.; Wang, W. T.; Wu, H. Tet-rahedron 2014, 70, 5274.
[48] Carney, D. W.; Nelson, C. D. S.; Ferris, B. D.; Stevens, J. P.; Lipovsky, A.; Kazakov, T.; DiMaio, D.; Atwood, W. J.; Sello, J. K. Bioorg. Med. Chem. 2014, 22, 4836.
[49] Manivannan, E.; Chaturvedi, S. C. Bioorg. Med. Chem. 2012, 20, 7119.
[50] Jacob, E. D.; Mathew, L.; Thomas, B. J. Chem. Sci. 2007, 119, 47.
[51] Zhuang, Q. Y.; Fu, Y. C.; Tang, D.; Zha, Y. Y.; Rong, L. C.; Tu, S. J. Chin. J. Org. Chem. 2010, 30, 1405(in Chinese). (庄启亚, 付永春, 唐丹, 查云赟, 荣良策, 屠树江, 有机化学, 2010, 30, 1405.)
[52] Darras, F. H.; Pockes, S.; Huang, G. Z.; Wehle, S.; Strasser, A.; Wittmann, H. J.; Nimczick, M.; Sotriffer, C. A.; Decker, M. ACS Chem. Neurosci. 2014, 5, 225.
[53] Huang, G. Z.; Roos, D.; Stadtmüller, P.; Decker, M. Tetrahedron Lett. 2014, 55, 3607.
[54] Rezaei, N.; Sheikhi, E.; Ranjbar, P. R. Synlett 2018, 29, 912.
[55] Azimi, S. B.; Azizian, J. Tetrahedron Lett. 2016, 57, 181.
[56] Bunce, R. A.; Nammalwar, B. J. Heterocycl. Chem. 2011, 48, 991.
[57] Shi, D. Q.; Rong, L. C.; Wang, J. X.; Zhuang, Q. Y.; Wang, X. D.; Hu, H. W. Tetrahedron Lett. 2003, 44, 3199.
[58] Cai, G. P.; Xu, X. L.; Li, Z. F.; Weber, W. P.; Lu, P. J. Heterocycl. Chem. 2002, 39, 1271.
[59] Su, W. K.; Yang, B. B. Aust. J. Chem. 2002, 55, 695.
[60] Yoo, C. L.; Fettinger, J. C.; Kurth, M. J. J. Org. Chem. 2005, 70, 6941.
[61] Su, W. K.; Yang, B. B. J. Chem. Res., Synop. 2002, 604.
[62] Upadhyaya, K.; Thakur, R. K.; Shukla, S. K.; Tripathi, R. P. J. Org. Chem. 2016, 81, 5046.
[63] Liu, Z. B.; Zeng, L. Y.; Li, Chao.; Yang, F. B.; Qiu, F. S.; Liu, S. W.; Xi, B. M. Molecules 2018, 23, 2325.
[64] Unsworth, W. P.; Kitsiou, C.; Taylor, R. J. K. Org. Lett. 2013, 15, 258.
[65] Kitsiou, C.; Unsworth, W. P.; Coulthard, G.; Taylor, R. J. K. Tetrahedron 2014, 70, 7172.
[66] Wu, X. F.; Oschatz, S.; Block, A.; Spannenberg, A.; Langer, P. Org. Biomol. Chem. 2014, 12, 1865.
[67] Borase, P. N.; Thale, P. B.; Shankarling, G. S. RSC Adv. 2016, 6, 63078.
[68] Safaei, H. R.; Shekouhy, M.; Ghorbanzadeh, S. ChemistrySelect 2018, 3, 4750.
[69] Zhen, B.; Jiao, Q. Z.; Zhang, Y. P.; Wu, Q.; Li, H. S.; Shi, D. X.; Li, J. R. Catal. Commun. 2013, 32, 1.
[70] Chai, H. X.; Li, J. R.; Yang, L. P.; Liu, M. X.; Yang, D. L.; Zhang, Q.; Shi, D. X. Chin. J. Chem. 2014, 32, 865.
[71] Tamaddon, F.; Pouramini, F. Synlett 2014, 25, 1127.
[72] Zhang, L. J.; Yu, J. L.; Wang, W. L.; Li, H.; Xu, D. D.; Bi, Y. D.; Liu, F. D. Tetrahedron Lett. 2014, 55, 710.
[73] Kundu, P.; Mondal, M.; Chowdhury, C. J. Org. Chem. 2016, 81, 6596.
[74] Zhang, X. P.; Li, Z. W.; Ding, Q. Q.; Li, X. C.; Fan, X. S.; Zhang, G. S. Adv. Synth. Catal. 2019, 361, 976.

2,3-二氢喹唑啉-4(1H)-酮类化合物的合成研究进展

Advances in Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones

PDF

可视化

被引次数

摘要/Abstract

引用此文

分享此文

参考文献

相关文章 15

编辑推荐

相关统计

本文评价

[1]	孟宪强, 杨艺, 梁万洁, 王靖涛, 张荣葵, 刘会. 钯催化联烯胺区域选择性芳基酚氧化反应[J]. 有机化学, 2024, 44(1): 224-231.
[2]	王兢睿, 冯永奎, 王能中, 黄年玉, 姚辉. 钯催化立体选择性合成硝基烷类β-碳糖苷[J]. 有机化学, 2023, 43(9): 3216-3225.
[3]	王玉超, 刘晋彪, 何智涛. 钯催化共轭二烯的不对称氢官能团化[J]. 有机化学, 2023, 43(8): 2614-2627.
[4]	向勋, 何照林, 董秀琴. 钯和手性磷酸协同催化高效构建手性分子的研究进展[J]. 有机化学, 2023, 43(3): 791-808.
[5]	孙美娇, 谭晶, 谭玉, 彭进松, 陈春霞. 钯催化3-(2-氨基嘧啶-4-基)吲哚2位C—H键芳基化反应的研究[J]. 有机化学, 2023, 43(11): 3945-3959.
[6]	熊威, 石斌, 姜烜, 陆良秋, 肖文精. 配体调控钯催化乙烯基环状碳酰胺和异氰酸酯的差异性转化[J]. 有机化学, 2023, 43(1): 265-273.
[7]	曹成瑶, 牛亚茹, 蒋昀辰, 曲红梅, 陈超. 钯催化的氯二氟乙基高价碘试剂对于乙酰苯胺C—H键的氯二氟乙基化反应研究[J]. 有机化学, 2022, 42(7): 2098-2105.
[8]	石宇冰, 白文己, 母伟花, 李江平, 于嘉玮, 连冰. 钯催化C—H键官能团化形成C—X (X=O, N, F, I, ……)键的密度泛函理论研究进展[J]. 有机化学, 2022, 42(5): 1346-1374.
[9]	陈宏超, 吴奕晨, 于洋, 王鹏. 钯催化的烯烃异构化反应[J]. 有机化学, 2022, 42(3): 742-757.
[10]	杨新拓, 陈品红, 刘国生. 钯催化烯烃的不对称Aza-Wacker反应: 高效合成手性1,3-噁嗪烷-2-酮[J]. 有机化学, 2022, 42(10): 3382-3389.
[11]	贾仕虎, 陈思元, 刘泽水, 程鸿刚, 周强辉. 钯/新型轴手性膦-烯配体催化的吲哚不对称烯丙基烷基化反应[J]. 有机化学, 2022, 42(10): 3373-3381.
[12]	张洁明, 倪航, 吴起, 杨俊锋, 张俊良. 钯催化的磷、硫和硅中心手性化合物的合成进展[J]. 有机化学, 2022, 42(10): 3118-3128.
[13]	韩阳, 姜为超, 张靖, 彭进松, 陈春霞. 可见光促进钯催化C—H键胺化反应合成咔唑醌衍生物的研究[J]. 有机化学, 2022, 42(1): 266-276.
[14]	张涛, 李尚达, 周春林, 王新超, 张孟, 高泽众, 李纲. 以芳基碘为碘化试剂的苯酚衍生物的位点选择性C—H键碘化反应[J]. 有机化学, 2021, 41(9): 3511-3520.
[15]	李晓颖, 李培贺, 王峥, 付辉, 戴啟谱. 钯催化的芳酰氧基氨基甲酸酯的分子内脱羧烯丙基胺化反应[J]. 有机化学, 2021, 41(8): 3089-3096.